Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Indaptus Therapeutics, Inc.INDP · Entity 6530 | 10% owner | August 10, 2023 | August 16, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Indaptus Therapeutics, Inc.
Report date August 10, 2023 · Filed August 16, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Anderson Family Trust u/a dtd 01/07/2018 | 1,131,402 |
Reported balance
After 2023-08-10 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-08-10 · Purchase · Acquired 44,354 · Balance 1,131,402 |
| Common StockSEC Table I · non-derivative | IndirectBy Anderson Family Trust u/a dtd 01/07/2018 | 1,166,466 |
Reported balance
After 2023-08-11 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2023-08-11 · Purchase · Acquired 35,064 · Balance 1,166,466 |
| Common StockSEC Table I · non-derivative | IndirectBy Anderson Family Trust u/a dtd 01/07/2018 | 1,190,400 |
Reported balance
After 2023-08-14 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2023-08-14 · Purchase · Acquired 23,934 · Balance 1,190,400 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2023 Filed Aug 16, 2023 18:01 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | PurchaseCommon Stock | 23,934 | $2.34 | $56,005.56 |
DisclosureSEC source: 0001493152-23-029212 · ownership.xml · nonDerivative · entry 3 Anderson Glen R. · CIK 0001878961 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Anderson Family Trust u/a dtd 01/07/2018 Disclosed balance after: 1,190,400 Read SEC document |
| August 11, 2023 Filed Aug 16, 2023 18:01 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | PurchaseCommon Stock | 35,064 | $2.12 | $74,335.68 |
DisclosureSEC source: 0001493152-23-029212 · ownership.xml · nonDerivative · entry 2 Anderson Glen R. · CIK 0001878961 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Anderson Family Trust u/a dtd 01/07/2018 Disclosed balance after: 1,166,466 Read SEC document |
| August 10, 2023 Filed Aug 16, 2023 18:01 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | PurchaseCommon Stock | 44,354 | $1.94 | $86,046.76 |
DisclosureSEC source: 0001493152-23-029212 · ownership.xml · nonDerivative · entry 1 Anderson Glen R. · CIK 0001878961 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Anderson Family Trust u/a dtd 01/07/2018 Disclosed balance after: 1,131,402 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.